Breaking news – Pagina 165 – AMD

Breaking news

Aprile 18, 2023 dario.olivero

Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial

Laugesen C, Ranjan AG, Schmidt S, Nørgaard K
Diabetologia. Pub. online 11 Apr 2023.

Leggi

Aprile 11, 2023 dario.olivero

Efficacy and safety of once‐weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: the AMPLITUDE‐D, AMPLITUDE‐L and AMPLITUDE‐S randomised controlled trials

Aroda VR, Frias JP, Ji L, et al.
Diabetes Obes Metab. Pub. online 4 Apr 2023.

Leggi

Aprile 11, 2023 dario.olivero

Does chronic low-dose aspirin use benefit bone health? A cross-sectional study on patients with type 2 diabetes mellitus

Zhang L, Ji X, Chen J, et al.
BMC Endocr Disord. 2023;23(1):79.

Leggi

Aprile 11, 2023 dario.olivero

Safety and efficacy of an adaptive bolus calculator for type 1 diabetes: a randomised control cross over study

Unsworth R, Armiger R, Jugnee N, et al.
Diabetes Technol Ther. Pub. online 5 Apr 2023.

Leggi

Aprile 11, 2023 dario.olivero

Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk

Serés-Noriega T, Ortega E, Giménez M, et al.
NMCD. Pub. online 4 Apr 2023.

Leggi

Aprile 11, 2023 dario.olivero

Bergenstal RM, Hachmann-Nielsen E, Kvist K, et al. Diabetes Technol Ther. Pub. online 5 Apr 2023.

Bergenstal RM, Hachmann-Nielsen E, Kvist K, et al.
Diabetes Technol Ther. Pub. online 5 Apr 2023.

Leggi

Aprile 5, 2023 dario.olivero

Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: the western denmark heart registry

Mortensen MB, Dzaye O, Bøtker HE, et al.
Circulation. 2023;147(14):1053-1063.

Leggi

Aprile 5, 2023 dario.olivero

Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: integrated analysis from the CANVAS Program and CREDENCE trial

Yi TW, Wong MMY, Neuen BL, et al.
Diabetes Obes Metab. Pub. online 27 Mar 2023.

Leggi

Aprile 5, 2023 dario.olivero

Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidemia

Ciaraldi TP, Boeder SC, Mudaliar SR, et al.
Diabetes Obes Metab. Pub. online 30 Mar 2023.

Leggi

Marzo 30, 2023 Alice Lione

Influenza: diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies

Dicembrini I, Silverii GA, Clerico A, et al.
NMCD. Pub. online, 26 Mar 2023

Leggi